Whole genome sequencing reveals host factors underlying critical Covid-19

March 7, 2022 | John Murphy | Leave a Comment

Whole genome sequencing reveals host factors underlying critical Covid-19

Authors: Athanasios Kousathanas, Erola Pairo-Castineira, J. Kenneth BaillieArticle Published: 07 March 2022 nature articles article We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the…[...]

March 6, 2022 | John Murphy | Leave a Comment

COVID-19 targets human adrenal glands

Authors: Waldemar Kanczkowski. Katja Evert. Marlena Stadtmüller, Martina Haberecker, Laura Laks, Lan-Sun Chen, et al. Published:November 18, 2021DOI:https://doi.org/10.1016/S2213-8587(21)00291-6PlumX Metrics COVID-19 develops due to infection with SARS-CoV-2, which particularly in elderly…[...]

March 4, 2022 | John Murphy | Leave a Comment

Arthritis drug reduces mortality in severe COVID-19, huge clinical trial finds

For hospitalized patients already taking other proven COVID-19 drugs, pill further reduces chance of death Authors: KAI KUPFERSCHMIDT 3 MAR 2022 1:20 PM Baricitinib, an oral drug that dampens an…[...]

March 4, 2022 | John Murphy | Leave a Comment

Pfizer’s COVID-19 Vaccine Goes Into Liver Cells And Is Converted To DNA: Study

Authors Meiling Lee THURSDAY, MAR 03, 2022 - 07:40 PM The messenger RNA (mRNA) from Pfizer’s COVID-19 vaccine is able to enter human liver cells and is converted into DNA,…[...]

March 3, 2022 | John Murphy | Leave a Comment

STUDY: PFIZER VACCINE FUSES WITH HUMAN DNA IN THE LIVER: CAUTION

Authors: Jules Gomes • ChurchMilitant.com • March 2, 2022 The mRNA from Pfizer's COVID-19 vaccine converts into DNA within six hours of entering the body's liver cells according to a groundbreaking study by Swedish researchers…[...]

March 2, 2022 | John Murphy | Leave a Comment

Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line

Authors: Markus Aldén 1,Francisko Olofsson Falla 1,Daowei Yang 1,Mohammad Barghouth 1,Cheng Luan 1,Magnus Rasmussen 2 andYang De Marinis 1,*1Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden2Infection Medicine, Department of Clinical Sciences, Lund University, 22362 Lund, Sweden Abstract…[...]

March 2, 2022 | John Murphy | Leave a Comment

Long-term cardiovascular outcomes of COVID-19

Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly Nature Medicine (2022)Cite this article368k Accesses Citations14239 AltmetricMetrics Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of…[...]

February 28, 2022 | John Murphy | Leave a Comment

Fighting COVID-19 with milk?

Authors: Elsevier As the COVID-19 pandemic continues to claim lives around the world, dairy scientists may have a surprising role to play. In a new report published in the Journal of…[...]

February 28, 2022 | John Murphy | Leave a Comment

COVID-19 and cerebrovascular diseases: a comprehensive overview

Authors: Georgios Tsivgoulis, Lina Palaiodimou, Ramin Zand First Published December 8, 2020 Review Article Find in PubMed https://doi.org /10.1177/1756286420978004 Abstract Neurological manifestations are not uncommon during infection with the novel severe acute respiratory syndrome coronavirus…[...]

February 28, 2022 | John Murphy | Leave a Comment

Potential pharmacologic treatments for COVID-19 smell and taste loss: A comprehensive review

Authors: Elnaz Khani,aSajad Khiali,aSamineh Beheshtirouy,a and Taher Entezari-Malekia,b,∗ Eur J Pharmacol. 2021 Dec 5; 912: 174582.Published online 2021 Oct 19. doi: 10.1016/ j.ejphar.2021.174582 PMCID: PMC8524700PMID: 34678243 Abstract The acute loss of taste and smell following COVID-19…[...]